Nanotechnology in healthcare and pharmaceuticals
High-ranking representatives of the Ministry of Health and Social Development, members of the Association of Russian Pharmaceutical Manufacturers, representatives of the world's largest pharmaceutical companies will speak at the section "Nanotechnology in Healthcare and Pharmaceuticals" of the IV International Forum "Rosnanotech 2011".
Basic questions:Reports of world-class experts on breakthrough technologies for creating nanovaccines and targeted drug delivery
- Creation of catalytic vaccines and nanodrugs based on encapsulated fragments of biopolymers
- Silicon nanoconstructions for the creation of antiviral drugs
- Nano-approaches to the development of new drugs for the treatment of bronchial asthma
- Nano-approaches to cancer therapy using viral particles and stem cells
- Round table "Nanotechnology – a breakthrough in genomics" with the invitation of specialists from leading companies developing projects in decoding human genetic information using microelectronics technology platforms.
- Discussion of the use of nanomaterials and nanomimetics of receptors and other biological polymers for medicine and biology.
- Nanomatrixes, analog and digital nanostructures for diagnostic purposes and the creation of three-dimensional matrices for the cultivation of organs and tissues from stem precursors, graphene structures for nanobiotechnology and modern methods of visualization of supramolecular complexes.
- Algorithms for constructing devices for performing medical procedures using microfabrication, microfluidic technologies and biopolymer composite materials.
- Reviews and discussions of breakthrough technologies in the field of regenerative medicine and stem cells. Stem cells of the brain, heart, blood, tissue engineering and their fate in the body, and the possibility of use in practice. The most important problem is induced stem cells for further application in medicine, a safety measure for their use.
Managers:
Konstantin Georgievich Scriabin, Academician of the Russian Academy of Sciences, Director, Bioengineering Center of the Russian Academy of Sciences (Russia);
Olga Yuryevna Shpichko, Managing Director, RUSNANO OJSC (Russia).
Program of the section "Nanotechnology in healthcare and pharmaceuticals"First day, October 26
15:00 – 18:00, Hall E
Plenary session. "Pharma: from idea to market"
Moderator: Sergey Alexandrovich Shulyak, CEO, DSM Group, Russia
15.00 – 15.30 Welcome speech
[TBD] Veronika Igorevna Skvortsova, Deputy Minister, Ministry of Health and Social Development, Russia
(hereafter “TBD" – to be determined, subject to clarification – VM)
[TBD] Denis Valentinovich Manturov, Deputy Minister, Ministry of Industry and Trade, Russia
Andrey Borisovich Malyshev, Deputy Chairman of the Management Board, RUSNANO, Russia
15.30 – 16.00 "On the results of the initial stage of the implementation of the Strategy for the development of the pharmaceutical industry of Russia"
Viktor Alexandrovich Dmitriev, President, Association of Russian Pharmaceutical Manufacturers, Russia
16.00 – 16.30 "10 years on the Russian market: a success story"
Alexey E. Repik, Chairman of the Board of Directors, R-Pharm, Russia
16.30 – 17.00 [TBD]
17.00 – 17.30 "Choosing a strategy: global horizons"
Dorman Followill, Partner, VP Healthcare, Frost & Sullivan, USA
17.30 – 18.00 "Venture investment in medicine and biotechnology: trends, successes and risks"
Brain Dovey, Partner, Domain Associates, USA
Second day, October 2709:30 – 13:30, Congress Center, 2nd floor (next to Hall H)
Open day for future doctors and biologists.
Laboratory workshop "Kits for kids"
09:30-10:45. Workshop 1 "DNA isolation: genes in the palm of your hand"
11:00-12:15. Workshop 2 "Enzyme immunoassay to track the spread of the disease".
12:15-12:30 Coffee break
12:30-13:30. Workshop 3 "Exclusive gel chromatography"
09:30 – 13:30, Hall H
Open day for future doctors and biologists.
Session "Medicine of the XXI century"
Co-Chairs:
[TBD] Gennady V. Shepelev, Director of the Department of Federal Targeted Programs and Projects, Ministry of Education and Science of Russia (USA),
[TBD] Professor Severinov Konstantin Viktorovich, Institute of Gene Biology of the Russian Academy of Sciences (Russia), Rutgers University (USA);
09.30 – 09.45 Welcome speech
[TBD] Igor Mikhailovich Remorenko, State Secretary – Deputy Minister of Education and Science of the Russian Federation, Russia
Andrey Gennadyevich Svinarenko, Deputy Chairman of the Management Board, RUSNANO, Russia
09.45 – 10.45 "Genomics and cancer"
Evgeny Davidovich Sverdlov, Academician of the Russian Academy of Sciences, Professor, Institute of Bioorganic Chemistry. Academicians M.M. Shemyakin and Yu.A. Ovchinnikov RAS, Russia
11.00 – 12.00 "The perfect molecular truck"
Konstantin Viktorovich Severinov, Professor, Institute of Gene Biology of the Russian Academy of Sciences (Russia), Rutgers University (USA);
12.15 – 12.30 Coffee break
12.30 – 13.30 Language and brain: how we think and speak"
Sergey Alexandrovich Shumsky, Chairman of the Board of Directors, IQmen, Russia
10:00 – 14:00, Hall F.
Session "Regenerative medicine – Stem cells" Part 1
Moderator: Grigory Nikolaevich Enikolopov, Professor, Cold Spring Harbor Laboratory, USA
13.00 – 13.30 "Hematopoietic stem cells"
Alexander Vadimovich Belyavsky, V. A. Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, Russia
10.00 – 10.30 "Heart stem cells"
Kenneth Chien, Professor, Harvard Stem Cell Institute, USA
10.30 – 11.00 "Three-dimensional visualization of transplanted stem cells in the heart of a rat after a heart attack using high-resolution X-ray microtomography"
Franco Rustichelli, Professor, Polytechnic University of Marca, Italy
11.00 – 11.45 "Allogeneic stem cell transplantation"
Jonas Mattson, Professor, Karolinska University, Sweden
11.45 – 12.00 Coffee break
12.00 – 12.30 "MIMS for stem cell research and cell regeneration"
Claude Leuchene, Professor, Harvard Medical School, USA
12.30 – 13.00 "Brain stem cells"
Grigory Nikolaevich Enikolopov, Professor, Cold Spring Harbor Laboratory, USA
13.30 – 14.00 "Application of genetically reprogrammed stem cells in regenerative medicine"
Sergey Lvovich Kiselyov, Professor, SIC "Kurchatov Institute", Russia
10:00 – 13:50, Hall E
Session "Nanotechnology in Drug Development: Strategies and examples" Part 1
Chairman: [TBD] Moderator: [TBD]
10.00 – 10.55 "Polymer nanoparticles: on the threshold of a revolution in medicine"
Omid Farokhzad, Professor, Director of the Laboratory of Nanomedicine and Biomaterials, Harvard Medical School, USA
10.55 – 11.45 "Targeted therapeutic nanoparticles: from discovery to clinical trials"
Scott Minick, President and CEO, BIND Biosciences, USA
11.40 – 12.00 Coffee break
12.00 – 12.50 "Visualization at the subcellular level of new molecular targets for targeted therapy"
Robert Hoffman, President, AntiCancer, USA
12.50 – 13.10 "REG1: breakthrough anticoagulant system for cardiovascular interventions in intensive care and intensive care"
David Mazzo, President and CEO, Regado Bioscences, USA
13.10 – 13.30 [TBD], Arno Therapeutics Peter Kash, President, Two Rivers Hospital, USA
13.30 – 13.50 "Nanotechnology in the treatment of wounds and inflammatory processes"
Bradford Duft, President and CEO, CoDa Therapeutics, USA
13:45 – 15:00 Lunch
15:00 – 17:00, Hall F. Session "Regenerative medicine – Stem cells" Part 2
Moderator: Grigory Nikolaevich Enikolopov, Professor, Cold Spring Harbor Laboratory, USA
15.00 – 15.30 "Stem cells and tissue equivalents as the basis of new bioengineering"
Andrey Valentinovich Vasiliev, Professor, Deputy Director, N.K. Institute of Developmental Biology Koltsova RAS (Russia), Russia
15.30 – 16.00 "Regeneration of the cornea using stem cells of the sclera limb"
Michele de Luca, Professor, University of Modena, Italy
16.00 – 16.45 Round table "Stem cells: achievements and obstacles on the way to therapy"
Grigory Nikolaevich Enikolopov, Professor, Cold Spring Harbor Laboratory, USA
16.45 – 17.00 Coffee break
15:00 – 17:30, Hall With
Round table "Key aspects of clinical trials in Russia"
Moderator: Eugene Selivra, CEO, Global Clinical Trials, USA
15.00 – 15.10 Opening remarks Eugene Selivra, CEO, Global Clinical Trials, USA
15.10 – 15.30 "Clinical trials: general view and regional features"
Eugene Selivra, CEO, Global Clinical Trials, USA
15.30 – 15.50 "Clinical trials in Russia: speed, price, quality"
Igor V. Stefanov, CEO, Synergy Research Group, Russia
15.50 – 16.10 "Clinical trials in Russia as part of the registration process"
Elena Kabaeva, Chief Medical Officer, Raifarm, Russia
16.10 – 16.30 "A look from abroad at clinical trials in Russia"
Edward Schnipper, Chief Medical Officer, BIND Biosciences, USA
16.30 – 17.30 Round table with Q&A audience
15:00 – 18:35, Hall E
Session "Nanotechnology in drug Development: Strategies and examples" Part 2
Chairman. Moderator: Rem Viktorovich Petrov, Academician of the Russian Academy of Sciences, RASKHN and RAMS, Doctor of Biological Sciences, Head of the Department, Institute of Bioorganic Chemistry named after M.M.Shemyakin and Yu.A. Ovchinnikov of the Russian Academy of Sciences, Russia
15.00 – 15.20 "New approaches for the treatment of macular dystrophy of the retina"
Ben Bronstein, CEO, Neuron Systems, USA
15.20 – 15.40 "Successful approaches in epigenetic regulation of signaling pathways of resistant solid tumors"
Peter Ordentlich, Executive Director, Syndax Pharmaceuticals, USA
15.40 – 16.00 "New nanoscale delivery systems for combined drugs: from promising research to therapeutically effective drugs"
Lawrence Mayer, Founder, President and Director of Research, Celator Pharmaceuticals, USA
16.00 – 16.20 "Sinbio Project"
Artur Alexandrovich Isaev, General Director, Human Stem Cell Institute, Russia
16.00 – 16.20 Coffee break
16.20 – 16.40 "Sonexa Therapeutics: the problem of Alzheimer's disease therapy"
Eckard Weber, CEO, Sonexa Therapeutics, USA
16.55 – 17.25 "NT-pharma – modern nanotechnologies in vaccine production"
Maxim Shmarov, Representative, NTfarma, Russia
17.25 – 17.55 "Tumor-specific gene vectors for cancer diagnosis and treatment"
Viktor Vladimirovich Krasnykh, Associate Professor of Experimental Diagnostic Imaging M.D., Anderson Cancer Center, University of Texas, USA
17.55 – 18.15 "Nanostabilizers for reviving the development of hydrophobic pharmaceuticals"
Ken Shaw, Senior Vice President of R&D, Marinus Pharmaceuticals, USA
18.15 – 18.35 "Study of antiviral properties of silicon nanoparticles"
Musa Rakhimovich Khaitov, Candidate of Medical Sciences, Head. Laboratory, Institute of Immunology, FMBA, Russia
17:00 – 18:30, Hall F
Meeting "Nanotechnology – a breakthrough in genomics"
17.00 – 17.30 "Semiconductor sequencing using microspheres"
Armin Winands, Executive Director and Scientific Director, DNA Electronics, USA
17.30 – 18.00 "New approaches to genomics"
Stevan Jovanovich, CEO, IntegenX, USA
18.00 – 18.30 [TBD] William La Rochelle, Head of Medical Program Development Department, Roche 454 Life Sciences, USA
17:30 – 19:40, Hall With
Seminar "Analytical Workshop: Resources for pharmaceutical companies and investors"
Moderator: Grigory Gennadievich Borisenko, Associate, RUSNANO, Russia
17.30 – 17.40 Opening remarks
Grigory Gennadievich Borisenko, RUSNANO, Russia
17.40 – 19.40 "Unified decision-making system for developers and entrepreneurs"
Gavin Coney, Director of Strategic Markets, Thomson Reuters, USA
Julia Dray, Intellectual Property and Science Manager, Thomson Reuters, USA
Demonstration of working with the Thompson Reuters analytical database. Q&A during the demonstration and at the end of the report.
Portal "Eternal youth" http://vechnayamolodost.ru based on the materials of the Rusnanoforum 2011 website
07.10.2011